Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reason the stock is down today: #msg-75107667.
Implications of Xeomin injunction on Botox sales: #msg-75107630.
~ Wednesday! $AGN ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!
~ $AGN ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=AGN&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=AGN&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=AGN
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=AGN#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=AGN+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=AGN
Finviz: http://finviz.com/quote.ashx?t=AGN
~ BusyStock: http://busystock.com/i.php?s=AGN&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=AGN >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
<<< $AGN Links! >>> ~ MAC's Quick DD Links without the charts.
PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/AGN
OTC Markets Company Info ~ http://www.otcmarkets.com/stock/AGN/company-info
OTC Markets Charts ~ http://www.otcmarkets.com/stock/AGN/chart
OTC Markets Quote ~ http://www.otcmarkets.com/stock/AGN/quote
OTC Markets News ~ http://www.otcmarkets.com/stock/AGN/news
OTC Markets Financials ~ http://www.otcmarkets.com/stock/AGN/financials
OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/AGN/short-sales
OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/AGN/insider-transactions
OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/AGN/research
Google Finance Summary ~ http://www.google.com/finance?q=AGN
Google Finance News ~ http://www.google.com/finance/company_news?q=AGN
Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=AGN
Google Finance Financials ~ http://www.google.com/finance?q=AGN&fstype=ii#
Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=AGN
Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=AGN&histperiod=weekly#
Y! < Company >
Y! Profile ~ http://finance.yahoo.com/q/pr?s=AGN+Profile
Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=AGN+Key+Statistics
Y! Headlines ~ http://finance.yahoo.com/q/h?s=AGN+Headlines
Y! Summary ~ http://finance.yahoo.com/q?s=AGN
Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=AGN+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=AGN+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/AGN
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/AGN
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=AGN+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=AGN+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=AGN+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=AGN+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=AGN+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=AGN+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=AGN+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=AGN+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=AGN+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=AGN+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=AGN+Cash+Flow&annual
FINVIZ ~ http://finviz.com/quote.ashx?t=AGN&ty=c&ta=0&p=d
Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=AGN
Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=AGN
Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=AGN
Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=AGN
Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=AGN
Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=AGN&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260
CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=AGN&exchange=US
Barchart Quote ~ http://barchart.com/quotes/stocks/AGN?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/AGN
Barchart Options Quotes ~ http://barchart.com/options/stocks/AGN
Barchart Technical Chart ~ http://barchart.com/charts/stocks/AGN&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/AGN&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/AGN
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=AGN
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/AGN
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/AGN
Barchart News Headlines ~ http://barchart.com/news/stocks/AGN
Barchart Profile ~ http://barchart.com/profile//AGN
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=AGN&view=key_statistics
OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=AGN&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=AGN&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=AGN&MarketTicker=NYSE&Typ=S
Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/AGN/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/AGN/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/AGN/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/AGN/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/AGN
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/AGN/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/AGN/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/AGN/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/AGN/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/AGN/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/AGN/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=AGN&sid=1795093&framed=False
The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=AGN
Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=AGN
StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=AGN&num1=567&cobrand=&mode=stock
StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=AGN
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=AGN
AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=AGN&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8
Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=AGN.PK&WTmodLOC=C4-Officers-5
StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=AGN®ion=U
Search NASDAQ ~ http://www.nasdaq.com/symbol/AGN
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/AGN/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/AGN/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/AGN/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=AGN&selected=AGN
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=AGN&selected=AGN
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/AGN/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/AGN/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/AGN/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/AGN/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/AGN/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/AGN/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/AGN/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/AGN/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/AGN/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/AGN/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/AGN/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/AGN/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/AGN/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/AGN/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=AGN&selected=AGN
NASDAQ Financials ~ http://www.nasdaq.com/symbol/AGN/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/AGN/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/AGN/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/AGN/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/AGN/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/AGN/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/AGN/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/AGN/insider-trades/sells
The Motley Fool ~ http://caps.fool.com/Ticker/AGN.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/AGN/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/AGN/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/AGN/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/AGN/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/AGN/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/AGN/Statements.aspx?source=icasittab0000009
MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=AGN
YCharts ~ http://ycharts.com/companies/AGN
YCharts Performance ~ http://ycharts.com/companies/AGN/performance
YCharts Dashboard ~ http://ycharts.com/companies/AGN/dashboard
InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=AGN&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=AGN&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=AGN&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=AGN
Zacks Quote ~ http://www.zacks.com/stock/quote/AGN
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=AGN
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=AGN
Knobias ~ http://knobias.10kwizard.com/files.php?sym=AGN
StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=AGN
Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/AGN/HOT_TOPIC.html
Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=AGN&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=AGN®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=AGN®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=AGN®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=AGN®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=AGN®ion=USA&culture=en-us
CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=AGN
TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=AGN
OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=AGN&searcharea=e&image1.x=0&image1.y=0
Insidercow ~ http://www.insidercow.com/history/company.jsp?company=AGN&B1=Search%21
Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=AGN
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=AGN&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=UNGS&start=1&max=10&searchResults=web&tag=web&sort=null
YouTube Symbol Search ~ http://www.youtube.com/results?search_query=AGN
Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=AGN
Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=AGN
Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=AGN
Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=AGN
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=AGN
Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=AGN
Investorpoint ~ http://www.investorpoint.com/ enter "AGN" and click search.
Hotstocked ~ http://www.hotstocked.com/ enter "AGN" and click search.
Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=AGN
Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=AGN
DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=AGN
SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=AGN
OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=AGN
Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "AGN" and click search.
http://www.coordinatedlegal.com/SecretaryOfState.html
http://regsho.finra.org/regsho-Index.html
http://www.shortsqueeze.com/?symbol=AGN&submit=Short+Quote%99
DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=AGN
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=AGN
Check those searches for recent AGN mentions. If AGN is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a complete list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS
MACDlinks
Actually, I didn't do any calculating at all. I am an Accountant by trade and do not trade stock professionally except in recent times as the job market has not suited my situation.
You will probably think this is another hocus pocus angle by some promoter, but I submit to you http://trademiner.com/. Don't worry, not many people use it. Looking at this stock's chart for just a few seconds and I can tell you it is very healthy stock. Note that a full percentage gain at this PPS today is, well, WOW.
Anyway, I can't say for sure. It is just a guess. And maybe you might attempt a short to prove me wrong. All I know, is I have seen this technology work over and over again and again. There you have it.
Bigdukeout!
No idea how you calculated your number. I'm all ears :- )
Hello Dew!
Can I call you that // Dew? Glad you responded to me because there is not much action (communication) going on here. As far as PPS, do you have an idea of how I might have calculated that? Just asking. Thanks.
Bigdukeout!
Good stock here. Good for a PPS of about $120 by June 15th or so.. Just sayin.
That’s standard boilerplate material. What is your point? Regards, Dew
It is Allergan’s policy to comply fully with Regulation FD. Therefore, Allergan intends to utilize this Webcast event to discuss financially oriented goals and objectives and to disclose material Company and industry-based topics in an open manner. Allergan does not plan to report or comment on its progress during the current fiscal quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to Allergan. During a quarter, Allergan’s commentary will be limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial. Allergan will make no comments with respect to market rumors or speculation.
AGN loses patent case on Sanctura XR: #msg-74026042.
WPI challenges AGN’s patents on Lumigan and Latisse: #msg-74006101.
New all-time high (eom).
AGN wins injunction against Botox-knockoff, Xeomin: #msg-72958753.
Reuters on AGN’s 4Q11 results: #msg-71656868.
4Q11 info on Botox, Dysport, and Xeomin: #msg-71648401, #msg-71652764.
2012 full-year non-GAAP EPS guidance is $4.13-4.19; 1Q12 non-GAAP EPS guidance is $0.84-0.86:
http://finance.yahoo.com/news/Allergan-Reports-Fourth-bwtmp-3702273155.html?x=0&.v=1&c=1
This video is bullish for AGN:
http://news.yahoo.com/video/us-15749625/bro-tox-more-men-get-botox-27833063.html
AGN reports 3Q11 non-GAAP EPS of $0.92:
#msg-68352499
Non-GAAP EPS guidance for 4Q11 is $0.97-0.99. For the full year 2011, non-GAAP EPS guidance was raised to $3.62-3.64 (from the old range of $3.59-3.63).
AGN will give 2012 guidance at the 4Q11 CC in late January or early February.
Botox notes from AGN’s 3Q11 CC: #msg-68361861.
How perceptions about Botox for cosmetic indications have changed during the past decade:
http://finance.yahoo.com/news/Awardwinning-Actress-Courtney-prnews-3879465155.html?x=0&.v=1
Weight Loss Surgery to Combat Type 2 Diabetes in Obese Patients
http://agn360.client.shareholder.com/releaseDetail.cfm?ReleaseID=606625
Bullish fluff piece on AGN from Reuters:
http://www.chicagotribune.com/business/sns-rt-us-allergantre78d2z5-20110914,0,2252351.story
Botox outsold Dysport 6:1 during 2Q11: #msg-66651517.
FDA approves Botox for urinary incontinence: #msg-66505064.
The R&D Day that CS refers to in the second paragraph from the bottom is scheduled for Mar 2012. FWIW
Wrinkles to Allergan Story Should Fade
http://online.barrons.com/article/SB50001424052702304576504576512781499730342.html?mod=BOL_twm_da
Allergan (NYSE: AGN)
By Credit Suisse ($74.75, Aug. 16, 2011)
We are upgrading shares of Allergan, the maker of Botox, to Outperform from Neutral.
The recent downturn in consumer sentiment and associated pullback in Allergan (ticker: AGN) stock provides an attractive entry point though ironically the company's prominent growth drivers are less economically sensitive.
Additional earnings-per-share (EPS) upside from sales or leverage may be more plausible given that the company's glaucoma franchise has better withstood new generic competition and investments will start to deliver returns.
There are three key points on valuation:
I) The consumer sentiment index has dropped to its lowest point since February 2009; historically such drops imply an attractive entry point;
II) Allergan has underperformed the S&P 500 by 186 basis points since mid-July even though its EPS growth has beat the S&P 500 in most years. Our projection for 14% 2010-2015 EPS compound annual growth rate (CAGR) bodes well for this continuing;
III) Allergan's exposure to disposable income is declining with about 82% of its 2010-2015 sales growth coming from less economically sensitive franchises.
Headwinds from the company's glaucoma franchise have not been an issue, whereas we were cautious that competitive pressures would be a factor. Lumigan prescriptions have continued to grow with demand in the last three months ranging from 8.5% to 13.8% growth, despite a new generic entrant to the prostaglandin category.
Commercial expenses for Botox migraine and other needs are factored into baseline assumptions about operating expenses and are better understood. To achieve guidance for sales, general and administration (SG&A) expense margin of 40%, Allergan will increase spending of this category by almost 11%.
This growth is higher than any of the last four years and strategically important to support the launch of Botox migraine and upcoming Levadex launch and successfully manage the glaucoma franchise. Visibility reduces the risk of consensus under-estimating this category, which makes up 57% of Allergan's total expenses.
With baseline operating expenses readjusted in 2011, expense growth is likely to decelerate in 2012, while investments start to pay off. While we appreciate that Allergan's strategy has never been frugality on expenses, it is very likely that they show some progression on operating margins as their past decisions reap leverage. We assume operating margin expansion of 130 basis points in 2012 versus 2011 and 440 basis points by 2015.
Allergan's R&D day may be an important catalyst with modest pipeline expectations. Only 4% of 2015 sales come from pipeline, with our sales 3% above the Street. It has been over three years since Allergan hosted such a meeting and Allergan's policy is short on disclosure in regards to its development projects.
Eye franchise forecasts are upward revised ($475 million in 2015) primarily driven by the better than expected performance of Lumigan post Xalatan generic entry in March 2011, a sign of solid execution.
It’s a little known fact that 50% of worldwide Botox sales come from non-cosmetic indications.
Allergan's BOTOX® Receives A Positive Opinion in Fourteen European Countries for Urinary Incontinence in Patients with MS or Spinal Cord Injury
BOTOX® injections can provide long-lasting bladder control for patients with neurogenic bladder
http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=597398
Update on Latisse for male/female pattern baldness: #msg-65829542.
AGN Posts Solid 2Q11 Results, Raises EPS Guidance
[Botox sales grew 16% YoY in dollars and 12% in local currencies to a $1.7B annualized rate. AGN raised full-year 2011 non-GAAP EPS guidance to $3.59-3.63 (up from $3.56-3.62). The company’s own 2Q11 PR is at http://finance.yahoo.com/news/Allergan-Reports-Second-bw-599082946.html?x=0&.v=1 .]
http://www.reuters.com/article/2011/08/03/allergan-idUSN1E7711U120110803
›Wed Aug 3, 2011 10:12am EDT
By Ransdell Pierson
NEW YORK, Aug 3 (Reuters) - Allergan Inc (AGN) reported higher second-quarter earnings on strong demand for its medical devices, prescription eye drugs, and Botox treatment for wrinkles and migraine headaches.
The company said on Wednesday that net income rose to $249 million, or 79 cents per share, from $241 million, or 78 cents per share, a year earlier. Excluding special items, earnings were 96 cents per share. Analysts on average expected 95 cents, according to Thomson Reuters I/B/E/S.
Sales rose almost 14 percent to $1.40 billion, topping Wall Street forecasts of $1.34 billion. They would have increased 9.6 percent if not for the weaker dollar, which drives up the value of sales in overseas markets.
Botox sales rose 16 percent to $418 million, helped by the product's recent approval to treat migraines and a somewhat stronger economy that has enabled more patients to pay out of pocket for cosmetic uses.
Prescription eye medicines, by far the company's biggest business, rose 14 percent to $658 million.
Sales of medical devices rose 12 percent to $245 million, fueled by demand for breast implants and dermal fillers. But sales of the company's Lap Band product, to treat obesity, continued to decline.
Allergan nudged up its full-year profit forecast to between $3.59 and $3.63 per share, excluding special items. It had previously expected $3.56 to $3.62.
Allergan shares were up 1 percent at $78.16 in morning trading on the New York Stock Exchange.‹
FDA approves Merz’s Xeomin for glabellar lines: #msg-65423443.
AGN buys private company for $75M (plus $200M earnout): #msg-65339902.
Fortune magazine on AGN’s winning ways:
http://money.cnn.com/2011/06/09/magazines/fortune/botox_allergan_patent_cliff_big_pharma.fortune/index.htm
The one notable point in the article is that investors and analysts may be underestimating the sales potential of Botox for migraine, an indication approved by the FDA in Oct 2010 (#msg-55606649).
AGN scores a reversal in appeal of Latisse case: #msg-63527133.
AGN set all-time intraday and closing highs today. It is (IMO) one of the best pharma plays on The Global Demographic Tailwind (#msg-62753229).
AGN Licenses Lucentis-Like Drug for Back-of-Eye Diseases:
#msg-62757686
This program has a lot of upside, but it’s only in phase-2.
$81.87, +4%, new all-time high.
Is anyone reading this board?
With 15% of sales and rapid growth in emerging markets, particularly from self-pay products such as Botox cosmetic, AGN is a play on The Global Demographic Tailwind (#board-15427) without the patent-cliff baggage of Big Pharma. AGN’s P/E ratio is much higher than Big Pharma companies, but the company’s product portfolio and near-flawless execution justify a relatively high P/E, IMO.
Highlights from AGN’s 1Q11 CC: #msg-62751639.
Musings on AGN’s prospects and valuation: #msg-59583715.
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
103
|
Created
|
04/03/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |